Figure 2.
Changes in National Health Insurance Reimbursement Criteria on (A) BMD measurement within 3 months post index hip fracture, (B) AOM prescription rate within 1 year post index hip fracture, (C) Subsequent osteoporotic fracture-related visit within 3 years post index hip fracture, and (D) Osteoporotic fracture-related healthcare expenditures within 3 years post index hip fracture per patient. Shadow means the period post reimbursement criteria change since January 2011. Abbreviations: BMD, bone mineral density; AOMs: anti-osteoporosis medications.